07/22/2024 | Press release | Distributed by Public on 07/22/2024 08:24
Key takeaways:
Suboxone (buprenorphine / naloxone) is a first-choice treatment for opioid use disorder (OUD). It can cause sexual side effects in both women and men.
Suboxone can affect the production of sex hormones, which can lead to erectile dysfunction, ejaculation problems, and decreased sex drive.
You are more likely to have sexual side effects from long-term opioid use than from taking Suboxone. Sexual side effects are also more likely with methadone compared to Suboxone. Methadone is another medication used to treat OUD.
If you or someone you know is affected by opioid use disorder (OUD), you're not alone. It's estimated that over 6 million people in the U.S. are living with opioid use disorder (OUD).
Medications are the gold standard for treating OUD. This approach is called medications for OUD, or MOUD for short. MOUD can help prevent relapse to opioids, lower the risk of overdose, and improve your quality of life.
Of the FDA-approved OUD medications, Suboxone (buprenorphine / naloxone) is a first-choice option. But Suboxone can cause side effects, including ones that might impact your sex life. Here, we'll discuss possible sexual side effects of Suboxone and how to manage them.
Medications for opioid use disorder: Medications are the gold standard for treating opioid use disorder (OUD). They're effective at preventing overdose and increasing your chances of staying opioid-free.
How Suboxone works: Suboxone (buprenorphine / naloxone) uniquely treats OUD and chronic pain.
Suboxone versus methadone: The two most effective medications for OUD are methadone and buprenorphine-containing medications like Suboxone. There are several differences between them.
It's possible, but Suboxone is less likely to cause side effects compared to continued opioid use. In fact, some research shows that starting Suboxone improvessexual function compared to continued opioid use. Suboxone is also less likely to cause sexual side effects compared to methadone (Methadose), another FDA-approved medication for OUD.
Still, some people may experience sexual side effects from Suboxone. Here's why.
Suboxone is a partial opioid agonist. It attaches to opioid receptors in the body. But it doesn't have the same effect as a regular ("full") opioid, such as hydrocodone or morphine (MS Contin).
Opioids (even "partial" ones like Suboxone) decrease the level of sex hormones in your body, including estrogen and testosterone. This can affect your sexual functioning.
However, other factors - such as stress levels, life events, and personal beliefs - can also affect your sex drive and ability to get an erection (erectile dysfunction).
Not to mention, chronic conditions like high blood pressure, uncontrolled diabetes, and kidney disease can cause sexual dysfunction. And many people with OUD also have mental health conditions that can affect sexual functioning. Depression, for example, can increase ED in men and lower arousal and desire in women.
Early studies of Suboxone didn't report sexual side effects. At this time, most of what we know about Suboxone and sexual side effects is based on studies of all opioids. So, it's hard to know for sure how common sexual side effects are with Suboxone. However, smaller studies have reported that over 80% of men taking Suboxone may experience sexual problems.
Research on sexual side effects of Suboxone in women is even more limited than it is in men. Historically, women - especially women of color - have been underrepresented in clinical research overall. A new law passed in 2024 may change this going forward. But for now, there's often less information on how medications, including Suboxone, affect women.
In men, lower-than-normal testosterone levels (hypogonadism) can lower sex drive and cause erectile dysfunction. And it's possible for Suboxone to lower testosterone levels.
But as mentioned, Suboxone is less likely to cause sexual dysfunction than continued opioid use. It's also less likely than methadone to lower testosterone.
Still, sexual side effects with Suboxone can happen. Possible risks include:
Trouble getting or maintaining an erection (erectile dysfunction)
Reaching orgasm too soon (premature ejaculation)
Trouble reaching orgasm (delayed ejaculation)
Lower sexual satisfaction
As mentioned earlier, it can be hard to tell if sexual problems are from Suboxone or something else. For example, Suboxone is just one of many medications that can cause erectile dysfunction. And there are many other possible causes, too.
Like men, opioids can have sexual side effects in women, including decreased sexual desire or trouble reaching orgasm. But still, sexual side effects are less likely with Suboxone versus continued opioid use.
And although Suboxone can lower testosterone production, we don't know for sure whether decreased testosterone levels affect women's sex drive like they do men's. But your body can change testosterone into estrogen. So by decreasing testosterone, Suboxone may indirectly lower estrogen levels (estrogen mainly influences women's sexual health).
In a survey of 56 women taking Suboxone, they didn't report more sexual problems than people who weren't taking Suboxone.
Concerns about sexual health are common, so your healthcare team is used to discussing them. While starting a conversation about this may feel uncomfortable at first, your care team can help you figure out what's causing your specific concerns and how to help.
Taking a look at daily habits is a good place to start when addressing sexual concerns. A few science-backed tips to help improve your sex life include:
Limit alcohol intake
Eat more fruits, vegetables, and whole grains
Get regular exercise, and practice yoga and/or meditation
Consider taking a sex education class (yes, there are ones for adults, too)
For men, ED medications, like sildenafil (Viagra) or tadalafil (Cialis), can help. And testosterone- replacement therapy has been shown to improve opioid-related low testosterone.
For premenopausal women, bremelanotide (Vyleesi) and flibanserin (Addyi) are FDA-approved options to improve sex drive. During or after the menopause transition, hormone therapy with estrogen (and a progestin like progesterone when needed) may help with sexual function, too. But it's not approved for treating sexual dysfunction. Talk to your prescriber about your options.
Methadone and buprenorphine-containing medications like Suboxone are the most commonly used types of medications for OUD. Naltrexone is also FDA approved for OUD, but it isn't prescribed as often.
As mentioned, sexual side effects are more likely with methadone versus Suboxone. In fact, people sometimes switch from methadone to Suboxone for this reason.
We don't have a lot of research comparing the sexual side effects of naltrexone and Suboxone. But one small study showed they cause a similar degree of sexual side effects.
Suboxone (buprenorphine / naloxone) is a first-choice medication for opioid use disorder (OUD). Treatment benefits include a higher chance of staying in remission and a lower risk of opioid overdose. But sexual side effects are possible risks of Suboxone. This includes erection problems (erectile dysfunction), decreased sexual desire (libido), and ejaculation problems.
While it's possible that Suboxone can cause sexual side effects, it's less likely to cause problems compared to methadone (Methadose), another FDA-approved medication for OUD. And it's possible that Suboxone actually improves sexual function for some people, since opioid misuse itself can cause sexual problems.
Talk to your care team if you're experiencing sexual side effects after starting Suboxone. They can help you decide what to do next.
American College of Obstetricians and Gynecologists. (2024). Hormone therapy for menopause.
American Diabetes Association. (n.d.). Sex and diabetes.
American Heart Association. (2024). How high blood pressure can affect your sex life.
American Society of Addiction Medicine. (2019). The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update.
American Urological Association. (n.d.). AUA Quality (AQUA) Registry.
Bierer, B. E., et al. (2022). Advancing the inclusion of underrepresented women in clinical research. Cell Reports Medicine.
Bryant Ranch Prepack. (2024). Buprenorphine and naloxone- buprenorphine and naloxone tablet [package insert].
Centers for Disease Control and Prevention. (2024). Managing sexual health with chronic kidney disease.
Cioe, P. A., et al. (2013). Change in symptoms of erectile dysfunction in depressed men initiating buprenorphine therapy. Journal of Substance Abuse Treatment.
de Vries, F., et al. (2020). Opioids and their endocrine effects: A systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism.
Endocrine Society. (2019). Another possible consequence of the opioid epidemic: Hormone deficiencies.
Endocrine Society. (2022). Reproductive hormones.
Grover, S., et al. (2014). Sexual dysfunction in patients with alcohol and opioid dependence. Indian Journal of Psychological Medicine.
Hallinan, R., et al. (2009). Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. International Journal of Andrology.
Ramdurg, S., et al. (2012). Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence. The Journal of Sexual Medicine.
Salata, B., et al. (2022). Opioid-induced sexual dysfunction in cancer patients. Cancers.
Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health.
The Menopause Society. (n.d.) Androgens, antidepressants, and other drugs on which the jury's still out.
The White House. (2024). Fact sheet: President Biden issues executive order and announces new actions to advance women's health research and innovation.
Vuong, C., et al. (2010). The effects of opioids and opioid analogs on animal and human endocrine systems. Endocrine Reviews.
Zamboni, L., et al. (2019). Sexual functioning and opioid maintenance treatment in women. Results from a large multicentre study. Frontiers in Behavioral Neuroscience.
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.